By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eurogentec today announced it has finalized technology transfer and licensing agreements with the BD Diagnostics division of Becton Dickinson.

One deal covers diagnostic manufacturing technology and the other is a multi-year supply agreement. Under the terms of the agreements, Eurogentec will provide BD Diagnostics with diagnostic manufacturing technology and technical assistance. BD expects to use the technology to develop molecular diagnostic kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.